92
L. S. Santos, R. A. Pilli
PAPER
8,8-Dimethyl-6,7-dimethyleneperhydro-indolizin-3-one (2c)
The same procedure as described above for 3a was employed start-
ing from 1c. Indolizidinone 2c was obtained in 67% yield as a yel-
low oil.
GC-MS: m/z (%) = 213 (78), 198 (5), 184 (5), 170 (8), 156 (4), 130
(100), 115 (54), 102 (4), 91 (7), 84 (28) and 77 (8).
HRMS (EI): m/z calcd for C14H15NO: 213.1154. Found: 213.1153.
8a (data from an enriched fraction of the mixture 7a–8a):
1H NMR (CDCl3) = 1.77 1.84 (m, 1 H, CH2CH2CO), 2.18 (s, 3
H, CH3), 2.20 2.34 (m, 1 H, CH2CH2CO), 2.35 2.43 (m, 2 H,
CH2CO), 3.81 3.87 (m, 1 H, CHN), 3.90 (d, J = 13.5, 1 H, CH2N),
4.69 (d, J = 13.5, 1 H, CH2N), 5.74 (d, J = 1.1, 1 H, CH=CCH3),
7.20 7.26(m, 1 H, CH-Ar), 7.32 7.37 (m, 3 H, CHAr).
IR (KBr): 2968, 2875, 1689, 1458, 1421, 1284, 1255 and 1182
1
cm .
1H NMR (CDCl3): 0.84 (s, 3 H, CH3), 1.11 (s, 3 H, CH3), 1.81
1.86 (m, 1 H, CH2CH2CO), 2.01 2.08 (m, 1 H, CH2CH2CO), 2.38
(t, J = 7.7, 2 H, CH2CO), 3.36 (dd, J = 8.4, 5.5, 1 H, CHN), 3.46 (d,
br, J = 14.6, 1 H, CH2N ), 4.60 (d, J = 14.6, 1 H, CH2N), 4.84 (s, br,
1 H, CH2=CCH2), 4.90 (s, br, 1 H, CH2=CCH2), 5.06 (s, br, 2 H,
CH2=CCCH3).
GC-MS: m/z (%) = 213 (23), 198 (100), 184 (4), 170 (6), 156 (9),
142 (6), 128 (12), 115 (14), 91 (6), 84 (3) and 77 (6).
13C NMR(CDCl3): 18.7 (CH2CH2CO), 20.0 (CH3), 22.1 (CH3),
30.3 (CH2CO), 40.1 (C(CH3)2), 45.7 (CH2N), 64.4 (CHN), 108.5
(CH2=C), 112.3 (CH2=C), 141.8 (C=CH2), 155.0 (C=CH2), 174.0
(CO).
10-Methyl-2,3,5,10,11,11a-hexahydro-1H-azolo[1,2-a]benzo-
[e]azepin-3-one (9a)
A 6.5:1 mixture of 7a–8a was dissolved in MeOH (5 mL) and
stirred for 10 h under H2 atmosphere (4 bar) at r.t. After evaporation
under reduced pressure and column chromatography (hexane
EtOAc, 1:1), a 4.5:1 mixture of 9a–10a was obtained in 94% yield.
HRMS (EI): m/z calcd for C12H17NO: 191.1310. Found: 191.1392.
5-Methyl-5,6,6a,7,8,9-hexahydroazolo[1,2-a]quinolin-9-one
(6a)
Data for the major isomer: white solid, mp 89–90 °C.
1
IR (KBr): 2962, 2922, 2875, 2852, 1682, 1489 and 760 cm .
The same procedure as described above for 3a was employed start-
ing from 1d. An inseparable 2:1 mixture of 5a–5b was obtained in
74% yield (HRMS [EI]: m/z calcd for C13H13NO: 199.0997; found:
199.0994) and dissolved in MeOH (2.0 mL). After addition of 10%
Pd/C (0.002 g),the resulting mixture was purged with H2 and stirred
for 8 h under H2 atmosphere (2 bar) at r.t.. Upon completion of the
reaction, the residue was filtered through a column of celite. Evap-
oration of the solvent under reduced pressure afforded 6a (0.024 g,
0.12 mmol, 20:1 mixture with 6b) in quantitative yield as a hygro-
scopic white solid.
1H NMR (CDCl3): 1.44 (d, J = 7.1, 3 H, CH3), 1.43 1.58(m, 1 H,
CH2CHCH3), 1.74 (m, 1 H, CH2CHCH3), 1.88 (dd, J = 14.5, 3.3, 1
H, CH2CH2CO), 2.19 2.37 (m, 3 H, CH2CH2CO and CH2CO),
3.20 3.29 (m, 1 H, CHN), 3.87 3.93 (m, 1 H, CHCH3), 4.09 (d, J
= 14.3, 1 H, CH2N), 4.97 (d, J = 14.3, 1 H, CH2N), 7.16 7.32 (m,
3 H, CHAr), 7.36 (m, 1 H, CHAr).
13C NMR (75 MHz, CDCl3): 20.6 (CH3), 24.9 (CH2CH2CO), 29.7
(CH2CO), 34.3 (CHCH3), 44.4 (CH2CHCH3), 46.0 (CH2N), 62.1
(CHN), 124.7 (CHAr), 126.5 (CHAr), 128.1 (CHAr), 129.9 (CHAr),
136.6 (CAr), 145.4 (CAr), 174.1(CO).
1
IR (KBr): 2962, 1687, 1485, 1092, 1024, 800 cm .
1H NMR (500 MHz, CDCl3): 1.37 (d, J = 6.8, 3 H, CH3), 1.50 (q,
J = 12.0, 1 H, CH2CHCH3), 1.70 1.75 (m, 1 H, CH2CH2CO), 2.20
(ddd, J = 12.0, 5.6, 2.4, 1 H, CH2CHCH3), 2.27 2.30 (m, 1 H,
CH2CH2CO), 2.47 2.57 (m, 1 H, CH2CO), 2.59 2.65 (m, 1 H,
CH2CO), 3.04 3.06 (m, 1 H, CHCH3), 3.95 3.97 (m, 1 H, CHN),
7.07 (dt, J = 7.8, 3.2, 1 H, CHAr), 7.21 (dt, J = 7.8, 1.0, 1 H, CHAr),
7.29 7.31 (m, 1 H, CHAr), 8.67 (dd, J = 8.5, 1.2, 1 H, CHAr).
13C NMR (125 MHz, CDCl3): 20.8 (CH3), 25.2 (CH2CH2CO),
31.4 (CHCH3), 32.0 (CH2CO), 39.3 (CH2CHCH3), 57.5 (CHN),
119.0 (CAr), 123.7 (CHAr), 126.8 (CHAr), 127.0 (CHAr), 130.7
(CHAr), 136.2 (CAr), 173.4 (CO).
HRMS (EI): m/z calcd for C14H17NO: 215.1310. Found: 215.1310.
11-Methyl-1,2,3,4,6,11,12,12a-octahydrobenzo[e]pyrido[1,2-
a]azepin-4-one (9b, 10b)
The same procedure as described above for 3a was employed start-
ing from 1f. After evaporation under reduced pressure, the residue
was purified by column chromatography (hexane EtOAc,
5:3 1:1) to afford an inseparable 2:1 mixture of 7b–8b in 90%
yield as a colorless oil.
GC-MS: 7b m/z (%) = 227 (76), 212 (5), 198 (3), 184 (5), 170 (10),
156 (6), 144 (7), 130 (100), 115 (5), 98 (5). 8b m/z (%) = 227 (31),
212 (100), 198 (23), 184 (13), 170 (13), 157 (21), 143 (8), 130 (21),
115 (22), 98 (21).
HRMS (EI): m/z calcd for C13H15NO: 201.1154. Found: 201.1153.
10-Methylene-2,3,5,10,11,11a-hexahydro-1H-azolo[1,2-a]ben-
zo[e]azepin-3-one (7a) and 10-Methyl-2,3,5,11a-tetrahydro-1H-
azolo[1,2-a]benzo[e]azepin-3-one (8a)
The same procedure as described above for 3a was employed start-
ing from 1e. After evaporation under reduced pressure, the residue
was purified by column chromatography (hexane-EtOAc, 1:1) to af-
ford a 6.5:1 mixture of 7a–8a in 80% yield as a colorless oil.
The above mixture was dissolved in MeOH (5.0 mL) and stirred for
10 h under H2 atmosphere (4 bar). After evaporation under reduced
pressure, a 6.5:1 mixture of 9b–10b was obtained in 98% yield.
Column chromatography (hexane EtOAc, 1:1) afforded the major
isomer 9b as a white solid: mp 114 115 °C.
IR (KBr): 3060, 3030, 2939, 2873, 1635, 1464, 1417, 1365, 1259,
1
1184 and 760 cm .
7a (data from an analytically pure sample):
1H NMR (500 MHz, CDCl3): 1.25 (d, J = 5.0, 3 H, CH3), 1.56
1.76 (m, 5 H, CH2CH2CH2, CH2CHCH3 and CH2CH2CO), 1.91
2.12 (m, 1 H, CH2CH2CO), 2.19 2.25(m, 1 H, CH2CO), 2.29 2.39
(m, 1 H, CH2CO), 3.26 3.33 (m, 1 H, CHN), 3.83 3.89 (m, 1 H,
CHCH3), 3.87 (d, J = 13.9, 1 H, CH2N), 5.30 (d, J = 13.9, 1 H,
CH2N), 7.16 7.26 (m, 3 H, CHAr), 7.45 (dd, J = 7.4, 1.5, 1 H,
CHAr).
13C NMR (125 MHz, CDCl3): 18.3 (CH3), 20.9 (CH2CH2CH2),
30.5 (CH2CH2CO), 32.8 (CH2CO), 35.4 (CHCH3), 44.6
(CH2CHCH3), 49.9 (CH2N), 61.4 (CHN), 124.7 (CHAr), 126.4
(CHAr), 127.7 (CHAr), 130.4 (CHAr), 137.7 (CAr), 145.0 (CAr), 169.3
(C).
1
IR (KBr): 3068, 2929, 1682 and 784 cm .
1H NMR(CDCl3): 1.77 1.81 (m, 1 H, CH2CH2CO), 2.20 2.36
(m, 1 H, CH2CH2CO), 2.38 2.46 (m, 3 H, CH2C= and CH2CO),
2.80 (dd, J = 13.2, 3.7, 1 H, CH2C= ), 3.91 (m, 1 H, CHN), 4.10 (d,
J = 15.0, 1 H, CH2N), 4.95 (d, J = 15.0, 1 H, CH2N), 5.20 (d, J =
1.5, 1 H, CH2=C), 5.25 (d, J = 1.5, 1 H, CH2=C), 7.22 7.32 (m, 4
H, CHAr).
13C NMR (CDCl3):
23.7 (CH2CH2CO), 29.8 (CH2CO), 43.0
(CH2=C), 45.9 (CH2N), 60.7 (CHN), 117.1 (CH2=C), 127.8
(CHAr, 2), 128.6 (CHAr), 128.7 (CHAr), 134.6 (CAr), 142.4 (CAr),
146.4 (C=CH2), 174.2 (CO).
Synthesis 2002, No. 1, 87–93 ISSN 0039-7881 © Thieme Stuttgart · New York